Information Provided By:
Fly News Breaks for October 9, 2017
Oct 9, 2017 | 08:11 EDT
Baird analyst Whit Mayo believes the HealthSouth story is very misunderstood and thinks the narrative ought to change. He said investors see too much risk for volume leakage, where as he sees more opportunity and a dislocated valuation. He also said industry tailwinds are greater than headwinds and he sees new partnerships, strategic alignment with payers, and an opportunity to scale its Home Health operation. Mayo reiterated his Outperform rating and raised his price target to $55 from $51 on HealthSouth shares.
News For HLS From the Last 2 Days
There are no results for your query HLS